 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., April 5, 2024 BRIDGEWATER...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...

Insmed's (NASDAQ:INSM) investors will be pleased with their favorable 56% return over the last year

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Insmed added to 'Q2 Tactical Ideas List' at Wells Fargo

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annexon Biosciences (ANNX Research Report) and Insmed...

Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference Insmed to Present New Data from Across its Respiratory Portfolio at the...

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

This is a Bullish indicator signaling INSM's price could rise from here. Traders may explore going long the stock or buying call options...

Insmed (INSM, $27.01) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 26, 2024

Diversified Trust Co increased its stake in Insmed Incorporated (NASDAQ:INSM  Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the...

Diversified Trust Co Acquires 972 Shares of Insmed Incorporated (NASDAQ:INSM)

Insmed (NASDAQ:INSM  Get Free Report) and Leap Therapeutics (NASDAQ:LPTX  Get Free Report) are both medical companies, but which is the better investment? We will compare the two...

Analyzing Insmed (NASDAQ:INSM) and Leap Therapeutics (NASDAQ:LPTX)

Adage Capital Partners GP L.L.C. bought a new position in shares of Insmed Incorporated (NASDAQ:INSM  Free Report) in the third quarter, according to its most recent 13F filing with the...

600,000 Shares in Insmed Incorporated (NASDAQ:INSM) Acquired by Adage Capital Partners GP L.L.C.

This indicator may be signaling INSM's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Insmed (INSM, $27.77) entered Uptrend as Momentum indicator ascends above 0 level on Mar 07, 2024

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Volume (M)	5.53M
52-Wk High	$32.00
52-Wk Low	$17.41

INSM Insmed Inc

About

Feed

News

Sentiment

Earnings

Fundamentals